CANDEL THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.15 USD | +0.42% |
|
-19.66% | +386.39% |
| May. 30 | FDA Grants Candel Therapeutics' CAN-3110 Orphan Drug Designation to Treat Recurrent High-Grade Glioma | MT |
| May. 30 | Candel Therapeutics Gets FDA's Orphan-Drug Status for Glioma Treatment | DJ |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-06-04 | 2024-06-05 | 2024-06-06 | 2024-06-07 | |
|---|---|---|---|---|
| Last | 8.04 $ | 8.03 $ | 7.12 $ | 7.15 $ |
| Volume | 371 188 | 588 003 | 827 852 | 811 289 |
| Change | -3.94% | -0.12% | -11.33% | +0.42% |
| Opening | 8.27 | 7.85 | 8.46 | 7.00 |
| High | 8.55 | 8.55 | 8.46 | 7.54 |
| Low | 7.94 | 7.85 | 7.12 | 6.76 |
Performance
| 1 day | +0.42% | ||
| 1 week | -19.66% | ||
| Current month | -19.66% | ||
| 1 month | -25.44% | ||
| 3 months | +367.32% | ||
| 6 months | +694.44% | ||
| Current year | +386.39% | ||
| 1 year | +373.51% |
Volumes
marketsDaily volume
811 812
Estimated daily volume
811 812
Avg. Volume 20 sessions
1 111 172
Daily volume ratio
0.73
Avg. Volume 20 sessions USD
7 944 879.80
Record volume 1
143 930 489
Record volume 2
84 150 545
Record volume 3
64 185 320
Capital turnover ratio
0.04
Float rotation
0.06
Basic data
Capitalization (USD)
211 862 755
Net sales (USD)
0
Number of employees
42
Sales / Employee (USD)
0
Free-Float
66 %
Free-Float capitalization (USD)
140 401 430
Average Daily Capital Traded
3.75%
Highs and lows
1 week
6.76
9.05
1 month
6.7614.30
Current year
1.1614.30
1 year
0.6614.30
3 years
0.6614.78
5 years
0.6614.78
10 years
0.6614.78
Indicators
Moving average 5 days
7.74
Moving average 20 days
9.91
Moving average 50 days
7.52
Moving average 100 days
4.57
Price spread / (MMA5)
+8.27%
Price spread / (MMA20)
+38.55%
Price spread / (MMA50)
+5.24%
Price spread / (MMA100)
-36.08%
STIM
RSI 9 days
33.46
RSI 14 days
41.18
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.42% | -19.66% | +386.39% | +373.51% | 212M | ||
| -2.38% | +5.93% | +51.85% | +20.22% | 59.28B | ||
| -1.22% | +2.84% | +41.42% | -14.20% | 40.94B | ||
| -0.57% | +0.06% | -5.25% | +5.11% | 40.17B | ||
| +0.42% | +8.46% | -5.16% | +12.15% | 28.69B | ||
| -0.85% | -1.71% | +12.79% | +41.11% | 26.63B | ||
| +2.33% | +2.93% | -20.18% | -19.66% | 18.89B | ||
| -0.47% | +3.84% | +30.88% | +80.51% | 12.46B | ||
| -1.52% | +0.57% | +0.61% | -5.62% | 12.42B | ||
| -0.51% | -0.05% | +25.06% | +24.63% | 12.26B | ||
| -3.08% | +3.05% | -9.14% | +5.57% | 11.42B | ||
| -0.18% | +3.68% | +0.17% | -3.15% | 9.97B | ||
| -0.76% | -2.97% | +20.69% | -13.84% | 6.64B | ||
| +0.47% | +5.24% | +40.66% | +49.91% | 6.62B | ||
| -1.03% | -2.10% | +12.03% | +72.15% | 6.54B | ||
| +0.25% | +5.79% | +3.78% | -21.58% | 6.35B | ||
| Average | -0.32% | +1.02% | +36.66% | +37.93% | ||
| Weighted average by Cap. | -0.15% | +3.04% | +18.56% | +12.74% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
46c8b7da3a394e5e19bc7.NAD0B4E4lWG0sC3eOKXTgVJcqUrt9I_G4txVjTD_3j8.a2OTQ-Nv_w7_2VmrTMfl1WYl-Qfew8akm4kXyX3Lkl5QRsZh5FT2LuXfbA
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 7.15 | 14,417 | 727,733 |
| 03:59:54 pm | 7.15 | 100 | 713,316 |
| 03:59:51 pm | 7.15 | 100 | 713,216 |
| 03:59:51 pm | 7.15 | 100 | 713,116 |
| 03:59:51 pm | 7.15 | 100 | 713,016 |
| 03:59:51 pm | 7.15 | 100 | 712,916 |
| 03:59:51 pm | 7.15 | 100 | 712,816 |
| 03:59:47 pm | 7.15 | 400 | 712,716 |
| 03:59:47 pm | 7.15 | 100 | 712,316 |
| 03:59:47 pm | 7.15 | 400 | 712,216 |
Monthly variations
Annual change
| 2024 | +386.39% | ||
| 2023 | -17.88% | ||
| 2022 | -77.11% | ||
| 2021 | +11.71% |
- Stock Market
- Equities
- CADL Stock
- Quotes Candel Therapeutics, Inc.
